By Christopher Holly — May 4, 2015
For over 45 years Dr. Charles Wiseman has pushed the envelope defining cancer treatment. In the 1970s he helped pioneer chemotherapy treatments for breast cancer now considered the standard of care. Today Dr. Wiseman is President of
BriaCell Therapeutics, a breast cancer immunotherapy company that has developed “BriaVax”, a patented whole-cell vaccine demonstrating highly encouraging Phase-I safety and efficacy data. For more about BriaCell and BriaVax check out the recent OZY feature
HERE
In early 2015
BriaCell joined the
Pasadena Bioscience Collaborative (PBC), the region’s only fully operational non-profit incubator, further cementing Pasadena’s growing reputation as a cutting edge hub of bio-medical R&D. For more on all PBC click
HERE